Skip to main content

Advertisement

Log in

MULTIPLE MYELOMA

Inflammatory stromal cells in the myeloma microenvironment

  • News & Views
  • Published:

From Nature Immunology

View current issue Submit your manuscript

Single-cell RNA sequencing identifies an inflammatory subpopulation of mesenchymal stromal cells in patients with multiple myeloma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Model of the interaction between iMSCs and tumor and immune cells.

References

  1. Dhodapkar, M. V. Blood 128, 2599–2606 (2016).

    Article  CAS  Google Scholar 

  2. Das, R. et al. Nat. Med. 22, 1351–1357 (2016).

    Article  CAS  Google Scholar 

  3. Zavidij, O. et al. Nat. Cancer 1, 493–506 (2020).

    Article  Google Scholar 

  4. Reagan, M. R. & Ghobrial, I. M. Clin. Cancer Res. 18, 342–349 (2011).

    Article  Google Scholar 

  5. de Jong, M. E. M. et al. Nat. Immunol. https://doi.org/10.1038/s41590-021-00931-3 (2021).

    Article  PubMed  Google Scholar 

  6. Baryawno, N. et al. Cell 177, 1915–1932.e16 (2019).

    Article  CAS  Google Scholar 

  7. Lemaitre, L. et al. Int. J. Mol. Sci. 21, 3854 (2020).

    Article  CAS  Google Scholar 

  8. Vande Broek, I. et al. Br. J. Cancer 88, 855–862 (2003).

    Article  CAS  Google Scholar 

  9. Qian, H., Le Blanc, K. & Sigvardsson, M. J. Biol. Chem. 287, 25795–25807 (2012).

    Article  CAS  Google Scholar 

  10. Munshi, N. C. et al. Blood Adv. 4, 5988–5999 (2020).

    Article  Google Scholar 

  11. Alameda, D. et al. Haematologica 105, e470–e473 (2020).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Irene M. Ghobrial.

Ethics declarations

Competing interests

R.S.P. has no competing interests to disclose. N.J.H. is a consultant for Constellation Pharmaceuticals. I.M.G has a consulting and advisory role with Celgene, Takeda, Bristol-Myers Squibb, Genentech, Janssen Pharmaceuticals and Amgen and has received research funding/honoraria from Celgene, Takeda, Bristol-Myers Squibb, Janssen Pharmaceuticals and Amgen. G.G. receives research funds from IBM and Pharmacyclics and is an inventor on patent applications related to MuTect, ABSOLUTE, MutSig, MSMuTect, MSMutSig, MSIdetect, POLYSOLVER and TensorQTL. G.G. is a founder, consultant and holds privately held equity in Scorpion Therapeutics.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sklavenitis-Pistofidis, R., Haradhvala, N.J., Getz, G. et al. Inflammatory stromal cells in the myeloma microenvironment. Nat Immunol 22, 677–678 (2021). https://doi.org/10.1038/s41590-021-00947-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-021-00947-9

  • Springer Nature America, Inc.

This article is cited by

Navigation